Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy

<p><strong>Introduction:</strong> Hypertrophic cardiomyopathy (HCM) is a leading cause of lethal arrhythmias in the young. Although the arrhythmic substrate has been hypothesised to be amenable to late Na+ block with ranolazine, the specific mechanisms are not fully understood. The...

Полное описание

Библиографические подробности
Главные авторы:	Coleman, JA, Doste, R, Beltrami, M, Argirò, A, Coppini, R, Olivotto, I, Raman, B, Bueno Orovio, A
Формат:	Journal article
Язык:	English
Опубликовано:	Frontiers Media 2024

Схожие документы

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
по: James A. Coleman, и др.
Опубликовано: (2024-04-01)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
по: Doste, R, и др.
Опубликовано: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
по: Coleman, J, и др.
Опубликовано: (2023)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
по: Palandri, C, и др.
Опубликовано: (2022)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
по: Passini, E, и др.
Опубликовано: (2015)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
по: Coleman, JA, и др.
Опубликовано: (2024)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
по: Akhtar Amin, и др.
Опубликовано: (2018-01-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
по: Ji-Jian Chow, и др.
Опубликовано: (2024-08-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
по: Chow, J, и др.
Опубликовано: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
по: Coleman, JA, и др.
Опубликовано: (2023)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
по: Coleman, JA
Опубликовано: (2024)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
по: Safa Daghem, и др.
Опубликовано: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
по: Margara, F, и др.
Опубликовано: (2022)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
по: Lyon, A, и др.
Опубликовано: (2018)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
по: Sílvia Aguiar Rosa, и др.
Опубликовано: (2021-12-01)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
по: Coleman, J
Опубликовано: (2024)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
по: Coppini, R, и др.
Опубликовано: (2019)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
по: George Joy, MD, и др.
Опубликовано: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
по: Francesca Margara, и др.
Опубликовано: (2022-12-01)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
по: Zakariye Ashkir, MD, и др.
Опубликовано: (2024-01-01)

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
по: Tatiana Saul, и др.
Опубликовано: (2024-12-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
по: S. M. Komissarova, и др.
Опубликовано: (2021-05-01)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
по: Lyon, A, и др.
Опубликовано: (2019)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
по: Doste, R, и др.
Опубликовано: (2021)

Computational probabilistic quantification of pro-arrhythmic risk from scar and left-to-right heterogeneity in the human ventricles
по: Wallman, M, и др.
Опубликовано: (2013)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
по: A. G. Osiev, и др.
Опубликовано: (2016-02-01)

Paradoxical prolongation of QT interval during exercise in patients with HCM: Cellular mechanisms and implications for diastolic function
по: Coppini, R, и др.
Опубликовано: (2022)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy
по: Raffaele Coppini, MD, PhD, и др.
Опубликовано: (2019-11-01)

High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence
по: Martinez-Navarro, H, и др.
Опубликовано: (2019)

HYPERTROPHIC CARDIOMYOPATHY IN MULTIMORBIDITY
по: A. I. Lakhonina, и др.
Опубликовано: (2016-06-01)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
по: Josè Manuel Pioner, и др.
Опубликовано: (2022-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
по: Mincholé, A, и др.
Опубликовано: (2015)

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
по: Ahmad Masri, и др.
Опубликовано: (2022-05-01)

Hypertrophic Cardiomyopathy: A Review
по: Brian A. Houston, и др.
Опубликовано: (2015-01-01)

Hypertrophic Cardiomyopathy: A Review
по: Brian A. Houston, и др.
Опубликовано: (2014-01-01)

Hypertrophic Cardiomyopathy
по: Asra K. Butt, и др.
Опубликовано: (2023-03-01)

Hypertrophic cardiomyopathy
по: Sarita Gore, и др.
Опубликовано: (2022-01-01)

Hypertrophic Cardiomyopathy
по: Polakit Teekakirikul, MD, и др.
Опубликовано: (2021-09-01)

Hypertrophic cardiomyopathy
по: Murillo de Oliveira Antunes, и др.
Опубликовано: (2020-04-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
по: Lyon, A, и др.
Опубликовано: (2018)